MEDINDIA
English
हिन्दी
Español
français
中文
Email
Aluminum Hydroxide
The serum concentration of Raltegravir can be decreased when it is combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The serum concentration of Raltegravir can be decreased when it is combined with Aluminum hydroxide.
Atorvastatin
Raltegravir may increase the myopathic rhabdomyolysis activities of Atorvastatin.
Bezafibrate
Raltegravir may increase the myopathic rhabdomyolysis activities of Bezafibrate.
Cerivastatin
Raltegravir may increase the myopathic rhabdomyolysis activities of Cerivastatin.
Ciprofibrate
Raltegravir may increase the myopathic rhabdomyolysis activities of Ciprofibrate.
Clofezone
The serum concentration of Raltegravir can be increased when it is combined with Rabeprazole.
Clofibrate
Raltegravir may increase the myopathic rhabdomyolysis activities of Clofibrate.
Dexlansoprazole
The serum concentration of Raltegravir can be increased when it is combined with Dexlansoprazole.
Esomeprazole
The serum concentration of Raltegravir can be increased when it is combined with Esomeprazole.
Etofibrate
Raltegravir may increase the myopathic rhabdomyolysis activities of Etofibrate.
Fenofibrate
Raltegravir may increase the myopathic rhabdomyolysis activities of Fenofibrate.
Fenofibric Acid
Raltegravir may increase the myopathic rhabdomyolysis activities of Fenofibric acid.
Fluvastatin
Raltegravir may increase the myopathic rhabdomyolysis activities of Fluvastatin.
Fosamprenavir
The serum concentration of Raltegravir can be decreased when it is combined with Fosamprenavir.
Gemfibrozil
Raltegravir may increase the myopathic rhabdomyolysis activities of Gemfibrozil.
Lansoprazole
The serum concentration of Raltegravir can be increased when it is combined with Lansoprazole.
Lovastatin
Raltegravir may increase the myopathic rhabdomyolysis activities of Lovastatin.
Magnesium Hydroxide
The serum concentration of Raltegravir can be decreased when it is combined with Magnesium hydroxide.
Magnesium Oxide
The serum concentration of Raltegravir can be decreased when it is combined with Magnesium oxide.
Magnesium Salicylate
The serum concentration of Raltegravir can be decreased when it is combined with Magnesium salicylate.
Magnesium Sulfate
The serum concentration of Raltegravir can be decreased when it is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The serum concentration of Raltegravir can be decreased when it is combined with Magnesium sulfate.
Omeprazole
The serum concentration of Raltegravir can be increased when it is combined with Omeprazole.
Pantoprazole
The serum concentration of Raltegravir can be increased when it is combined with Pantoprazole.
Pitavastatin
Raltegravir may increase the myopathic rhabdomyolysis activities of Pitavastatin.
Pravastatin
Raltegravir may increase the myopathic rhabdomyolysis activities of Pravastatin.
Rabeprazole
The serum concentration of Raltegravir can be increased when it is combined with Rabeprazole.
Rifabutin
The serum concentration of Raltegravir can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Raltegravir can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Raltegravir can be increased when it is combined with Rifapentine.
Rilpivirine
The serum concentration of Raltegravir can be increased when it is combined with Rilpivirine.
Rosuvastatin
Raltegravir may increase the myopathic rhabdomyolysis activities of Rosuvastatin.
Simvastatin
Raltegravir may increase the myopathic rhabdomyolysis activities of Simvastatin.
Tipranavir
The serum concentration of Raltegravir can be decreased when it is combined with Tipranavir.
Zidovudine
Raltegravir may increase the myopathic rhabdomyolysis activities of Zidovudine.
